Preventing Antibiotic-Associated DiarRhea Using Erceflora

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To determine the effectiveness of the pre-biotic Bacillus clausii in preventing antibiotic associated diarrhea among hospitalized immunocompetent Filipino children.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sanofi
• Treatments: Anti-Bacterial Agents

Criteria

Inclusion Criteria:

• Clinically stable children with mild to moderate illness admitted for treatment of bacterial infection.

Exclusion Criteria:

• Children with unstable medical condition

• In any form of immunocompromized state

• With contraindication to take medication

• Has taken antibiotics for 3 weeks before start of trial.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.